A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases

A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases

Aim. Study the effect of a study video, which was created by researchers and devoted to the atherosclerosis development and the effect of statin therapy on atherosclerotic plaque, on adherence to long-term therapy in patients with high or very high risk of cardiovascular complications.Material and m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva
Format:	Article
Language:	English
Published:	Столичная издательская компания 2021-11-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	cardiovascular disease adherence statins educational video cholesterol
Online Access:	https://www.rpcardio.online/jour/article/view/2577
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Statins: Adherence and side-effects
by: D.J. Blom
Published: (2011-07-01)

Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
by: Victoriya N. Serebryakova, et al.
Published: (2021-01-01)

APPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENT
by: S. A. Shalnova, et al.
Published: (2018-04-01)

Adherence to statin therapy in patients with high and very high cardiovascular risk in real clinical practice
by: V. I. Podzolkov, et al.
Published: (2020-03-01)

Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care data
by: Deniz Türkmen, et al.
Published: (2025-07-01)

STUDY OF ADHERENCE TO DRUG THERAPY OF PATIENTS WITH CARDIOVASCULAR DISEASES IN DISTRICT HOSPITAL OF SMALL TOWN IN SARATOV REGION AND IN CARDIOLOGY DEPARTMENT OF UNIVERSITY CLINIC IN SARATOV
by: Yu. V. Bulaeva, et al.
Published: (2018-07-01)

Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysisResearch in context
by: Deborah Keng Wai Yow, et al.
Published: (2025-06-01)

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01)

Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

The treatment of cholesterol: issues, effects and targets
by: James A. Ker
Published: (2010-12-01)

Effectiveness of patient-oriented intervention in primary prevention of cardiovascular diseases with statins: Open-label randomized study
by: Elena Bochkareva, et al.
Published: (2025-06-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review
by: Subodh Bashyal, et al.
Published: (2025-07-01)

Challenges in managing adherence in patients with cardiovascular disease (review)
by: Yu. S. Ignatova, et al.
Published: (2025-01-01)

Medication adherence of cardiovascular patients after COVID-19: 6-month follow-up
by: A. R. Tyapaeva, et al.
Published: (2024-04-01)

TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT
by: D. V. Nebieridze, et al.
Published: (2017-12-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

Pharmacological Profile and Mechanisms of Cardiovascular Protective Effects of Statins: An Update
by: Abdalla Salem Elhwuegi, et al.
Published: (2025-06-01)

Newly Started Versus Previously Treated Statin Patients: A Retrospective Cohort Study Comparing Adherence and Persistence with Reference to Cardiovascular Prevention
by: Marta Martín-Fernández, et al.
Published: (2025-04-01)

Triglyceride/high density lipoprotein cholesterol index and future cardiovascular events in diabetic patients without known cardiovascular disease
by: Ryosuke Nakashima, et al.
Published: (2025-03-01)

ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW
by: O. N. Semenova, et al.
Published: (2015-09-01)

Adherence to pharmacotherapy for secondary prevention of coronary heart disease: A registry-based prospective study
by: Aradhai Bana, et al.
Published: (2025-03-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Evaluating Readability, Understandability, and Actionability of Online Printable Patient Education Materials for Cholesterol Management: A Systematic Review
by: Chaitanya Bhatt, et al.
Published: (2024-04-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Atherosclerosis pathogenesis from the perspective of microvascular dysfunction
by: D. M. Aronov, et al.
Published: (2021-11-01)

The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
by: Marina G. Bubnova, et al.
Published: (2025-01-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Relationship Between Depression and Medication Adherence in Older Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
by: Mina Berimavandi, et al.
Published: (2025-05-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
by: Alberto Zambon
Published: (2020-04-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Hypolipidemic effectiveness and safety of generic lovastatin
by: D. M. Aronov, et al.
Published: (2006-12-01)

Statin therapy for NAFLD: Molecular underpinnings of myopathic consequences and treatment strategies
by: Pratiksha Nanepag, et al.
Published: (2025-06-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action
by: Martina Berteotti, et al.
Published: (2025-06-01)

Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study
by: Andrej Belančić, et al.
Published: (2025-06-01)

Biochemical, structural and clinical analysis of statins’ pleiotropic effects
by: A. N. Britov, et al.
Published: (2009-10-01)